Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT01987999

A Nutraceutical Intervention in Patients With Previously Untreated Human Prostate Cancer

Conditions: Prostate Cancer

Sex: Male
Ages: 40 Years – 75 Years
Healthy volunteers: No
Phase: PHASE2
Enrollment: 60
Sponsor: Optimal Health Research

Summary

The purpose of this study is to evaluate weather a novel nutraceutical intervention (F-989) can improve prostate-specific antigerm (PSA) levels and Gleason scores in prostate cancer patients who are on active surveillance.

Eligibility Criteria

Inclusion Criteria: * Clinical diagnosis of prostate cancer (PSA + biopsy) * Referred to the study by their treating physician Exclusion Criteria: \- Any type of treatment before starting the study

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT01987999). StuddyBuddy aggregates publicly available trial information.